OpenVSafe by OpenVAERS
Search V-safe

G3D-33661-33139

2 vaccinations 3 coded responses 11 check-ins 3 free-text entries 2 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
117 / NY
Registered
2021-01-16
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-15
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-16
    Registered in v-safe
  3. 2021-01-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Chills, Headache, Fatigue or tiredness
    Adult check-in
  4. 2021-01-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  5. 2021-01-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache
    Adult check-in
  6. 2021-01-29
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  7. 2021-02-05
    Dose 2 — Pfizer-BioNTech
  8. 2021-02-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea
    Adult check-in
  9. 2021-02-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  10. 2021-02-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Muscle or body aches
    Adult check-in
  11. 2021-02-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  12. 2021-02-12
    Survey response — day 7, dose 2
    MedDRA: Contusion — Feeling: Good · Muscle or body aches
    Free text: Bruising of unknown origin on legs
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-05-07
    Survey response — 3 months, dose 2
    MedDRA: Amenorrhoea, Autoimmune thyroiditis, Blood cholesterol increased, Blood thyroid stimulating hormone increased, Office visit, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Hashimotos disease (astronomical TSH level of 69) (baseline was 1.4), elevated cholesterol 440 total and baseline cholesterol was under 200 prior to receiving the vaccine. I also have not had a period since receiving the second dose and NOT PREGNANT · Healthcare visit (other): In person visit with primary, endocrinologist and cardiologist
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-05-07
    Report sent to call center — 3 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  15. 2022-02-05
    Survey response — 12 months, dose 2
    MedDRA: Arthritis, Chest pain, Hepatic enzyme increased, Hypothyroidism, Inflammation, Lipids increased, Malaise, Office visit — Feeling: Poor · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Severe inflammatory immune response to the second dose of Pfizer. Severe acute hypothyroidism, inflammation in joints, elevated liver enzymes, elevated lipid panel, all previously normal. Chest pain and malaise · Healthcare visit (other): Visit with my primary care provider
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-02-05
    Report sent to call center — 12 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  17. 2022-02-07

Vaccinations

DoseDateManufacturerCo-administered
12021-01-15Pfizer-BioNTech
22021-02-05Pfizer-BioNTech

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 4 — day 7, dose 2

2021-02-12

Systemic reaction (other): Bruising of unknown origin on legs

Release 8 — 3 months, dose 2

2021-05-07

Symptoms: Hashimotos disease (astronomical TSH level of 69) (baseline was 1.4), elevated cholesterol 440 total and baseline cholesterol was under 200 prior to receiving the vaccine. I also have not had a period since receiving the second dose and NOT PREGNANT cut off by CDC
Healthcare visit (other): In person visit with primary, endocrinologist and cardiologist

Release 11 — 12 months, dose 2

2022-02-05

Symptoms: Severe inflammatory immune response to the second dose of Pfizer. Severe acute hypothyroidism, inflammation in joints, elevated liver enzymes, elevated lipid panel, all previously normal. Chest pain and malaise
Healthcare visit (other): Visit with my primary care provider

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit ✓ ✓ ✓
SDAmenorrhoea ✓ · ✓
SDArthritis · · ✓
SDAutoimmune thyroiditis ○ ✓ ○
SDBlood cholesterol increased ✓ ✓ ✓
SDBlood thyroid stimulating hormone increased ✓ · ✓
SDChest pain · · ✓
SDHepatic enzyme increased · · ✓
SDHypothyroidism · · ✓
SDInflammation · · ✓
SDLipids increased · · ✓
SDMalaise · · ✓
SDPre-existing disease ✓ · ✓
SROContusion ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release